I agree that this site is using cookies. You can find further informations here.
X
Ahlberg, Lucia
35  results:
Search for persons X
?
1

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

Survival in adult acute lymphoblastic leukaemia (ALL): A re..:

Lennmyr, Emma ; Karlsson, Karin ; Ahlberg, Lucia...
European Journal of Haematology.  103 (2019)  2 - p. 88-98 , 2019
Link: https://doi.org/10.1111/..
 
?
3

Bortezomib‐based therapy for relapsed/refractory multiple m..:

Terpos, Evangelos ; Katodritou, Eirini ; de la Rubia, Javier...
European Journal of Haematology.  101 (2018)  4 - p. 556-565 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Lenalidomide versus lenalidomide + dexamethasone prolonged ..:

Lund, Johan ; Gruber, Astrid ; Lauri, Birgitta...
Cancer Medicine.  7 (2018)  6 - p. 2256-2268 , 2018
Link: https://doi.org/10.1002/..
 
?
5

Age but not Philadelphia positivity impairs outcome in olde..:

Kozlowski, Piotr ; Lennmyr, Emma ; Ahlberg, Lucia...
European Journal of Haematology.  99 (2017)  2 - p. 141-149 , 2017
Link: https://doi.org/10.1111/..
 
?
6

Pharmacogenetic study of the impact of ABCB1 single-nucleot..:

Jakobsen Falk, Ingrid ; Lund, Johan ; Gréen, Henrik...
Cancer Chemotherapy and Pharmacology.  81 (2017)  1 - p. 183-193 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Satisfactory outcome after intensive chemotherapy with prag..:

Bergfelt, Emma ; Kozlowski, Piotr ; Ahlberg, Lucia...
Medical Oncology.  32 (2015)  4 - p. , 2015
Link: https://doi.org/10.1007/..
 
?
8

High relapse rate of T cell acute lymphoblastic leukemia in..:

Kozlowski, Piotr ; Åström, Maria ; Ahlberg, Lucia...
European Journal of Haematology.  92 (2014)  5 - p. 377-381 , 2014
Link: https://doi.org/10.1111/..
 
?
9

Effect of pamidronate 30 mg versus 90 mg on physical functi..:

Gimsing, Peter ; Carlson, Kristina ; Turesson, Ingemar...
The Lancet Oncology.  11 (2010)  10 - p. 973-982 , 2010
Link: https://doi.org/10.1016/..
 
?
10

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer. 2022, 22:147 (1), 1-11..  , 2022
Link: https://hdl.handle.net/1..
 
?
11

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brondum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer, 1471-2407, 2022, 22:1,.  , 2022
Link: http://urn.kb.se/resolve..
 
?
12

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818194/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus F ; Johnsen, Hans E...
http://urn.nb.no/URN:NBN:no-93244.  , 2022
Link: http://hdl.handle.net/10..
 
?
14

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
Schmitz , A , Brøndum , R F , Johnsen , H E , Mellqvist , U H , Waage , A , Gimsing , P , Op Bruinink , D H , van der Velden , V , van der Holt , B , Hansson , M , Andersen , N F , Frølund , U C , Helleberg , C , Schjesvold , F H , Ahlberg , L , Gulbrandsen , N , Andreasson , B , Lauri , B , Haukas , E , Bødker , J S , Roug , A S , Bøgsted , M , Severinsen , M T , Gregersen , H , Abildgaard , N , Sonneveld , P & Dybkær , K 2022 , ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ' , BMC Cancer , vol. 22 , no. 1 , 147 , pp. 147 . https://doi.org/10.1186/s12885-022-09184-1.  , 2022
Link: https://pure.eur.nl/en/p..
 
?
15

Longitudinal minimal residual disease assessment in multipl..:

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
Schmitz , A , Brøndum , R F , Johnsen , H E , Mellqvist , U H , Waage , A , Gimsing , P , op Bruinink , D H , van der Velden , V , van der Holt , B , Hansson , M , Andersen , N F , Frølund , U C , Helleberg , C , Schjesvold , F H , Ahlberg , L , Gulbrandsen , N , Andreasson , B , Lauri , B , Haukas , E , Bødker , J S , Roug , A S , Bøgsted , M , Severinsen , M T , Gregersen , H , Abildgaard , N , Sonneveld , P & Dybkær , K 2022 , ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ' , BMC Cancer , vol. 22 , no. 1 , 147 . https://doi.org/10.1186/s12885-022-09184-1.  , 2022
Link: https://pure.au.dk/porta..
 
1-15